Aperçu rapide pour Synovial Sarcoma, X Breakpoint 2 Interacting Protein (SSX2IP) Peptide (ABIN984472)
Antigène
SSX2IP
(Synovial Sarcoma, X Breakpoint 2 Interacting Protein (SSX2IP))
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
Attributs du produit
This is a synthetic peptide designed for use in combination with anti-SSX2IP antibody (Catalog #: ARP53690_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Each Investigator should determine their own optimal working dilution for specific applications.
Restrictions
For Research Use only
Format
Lyophilized
Reconstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Concentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Conseil sur la manipulation
Avoid repeated freeze-thaw cycles.
Stock
-20 °C
Stockage commentaire
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Antigène
SSX2IP
(Synovial Sarcoma, X Breakpoint 2 Interacting Protein (SSX2IP))
Sujet
SSX2IP belongs to an adhesion system, which plays a role in the organization of homotypic, interneuronal and heterotypic cell-cell adherens junctions (AJs). It may connect the nectin-afadin and E-cadherin-catenin system through alpha-actinin and may be involved in organization of the actin cytoskeleton at AJs through afadin and alpha-actinin.
Alias Symbols: ADIP, FLJ10848, KIAA0923, MGC75026
Protein Interaction Partner: ACTN1,ACTN2,MLLT4,SSX2,SSX2IP,SSX3,ACTN1,MLLT4,USP11